home / stock / bmndf / bmndf short
Short Information | Biomind Labs (OTCMKTS:BMNDF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 99,606 |
Total Actual Volume | 141,113 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 16 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 4,980 |
Average Short Percentage | 81.98% |
Is there a BMNDF Short Squeeze or Breakout about to happen?
See the BMNDF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $0.35 | $0.35 | $0.35 | $0.35 | 100 | 100 | 100% |
03-22-2024 | $0.35 | $0.34 | $0.35 | $0.34 | 663 | 13 | 1.96% |
03-18-2024 | $0.2466 | $0.3 | $0.3 | $0.2466 | 7,497 | 3,125 | 41.68% |
03-15-2024 | $0.36 | $0.36 | $0.36 | $0.36 | 147 | 147 | 100% |
03-11-2024 | $0.36 | $0.36 | $0.36 | $0.36 | 100 | 100 | 100% |
03-08-2024 | $0.2348 | $0.2456 | $0.2456 | $0.2348 | 3,147 | 147 | 4.67% |
03-06-2024 | $0.36 | $0.36 | $0.36 | $0.36 | 1,300 | 1,000 | 76.92% |
03-04-2024 | $0 | $0.3628 | $0 | $0 | 100 | 100 | 100% |
03-01-2024 | $0.49 | $0.3628 | $0.5739 | $0.3628 | 3,161 | 3,061 | 96.84% |
02-29-2024 | $0.0898 | $0.2993 | $0.5298 | $0.0887 | 119,424 | 86,464 | 72.4% |
02-26-2024 | $0.1064 | $0.1064 | $0.1064 | $0.1064 | 200 | 200 | 100% |
02-16-2024 | $0 | $0.1003 | $0 | $0 | 10 | 10 | 100% |
02-12-2024 | $0.1003 | $0.1003 | $0.1003 | $0.1003 | 1,825 | 1,825 | 100% |
02-07-2024 | $0.1 | $0.1 | $0.1 | $0.1 | 2,000 | 2,000 | 100% |
11-06-2023 | $0.1 | $0.1 | $0.1 | $0.1 | 100 | 100 | 100% |
08-04-2023 | $0 | $0.52 | $0 | $0 | 52 | 52 | 100% |
07-28-2023 | $0 | $0.52 | $0 | $0 | 52 | 52 | 100% |
02-10-2023 | $0 | $0.5209 | $0 | $0 | 1,006 | 1,000 | 99.4% |
01-26-2023 | $0.6822 | $0.625 | $0.6822 | $0.625 | 219 | 100 | 45.66% |
11-15-2022 | $0 | $1.52 | $0 | $0 | 10 | 10 | 100% |
News, Short Squeeze, Breakout and More Instantly...
TORONTO, ON / ACCESSWIRE / July 18, 2024 / Biomind Labs Inc. (" Biomind " or the " Company ") (CBOE:BMND) (OTC PINK:BMNDF) (FRA:3XI) , a leading biotech company dedicated to developing the next-generation of pharmaceuticals targeting the root causes of neurological disorders, announced the ...
Biomind Labs Inc. (“ Biomind ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeti...
Biomind Labs Inc. (“ Biomind Labs ” or the “ Company ”) ( NEO: BMND ) ( OTC: BMNDF ) ( FSE: 3XI ), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by ta...